摘要
目的:采用Framingham心血管危险评分(FRS)探讨2型糖尿病患者合并代谢综合征对10年心血管疾病风险的影响。方法:入选1708例于2008年5月至2013年4月在浙江大学医学院附属第二医院住院治疗的2型糖尿病患者,测定人体形态学和生化指标。采用ATPm2005亚洲标准诊断代谢综合征,按不同性别分为未合并代谢综合征组和合并代谢综合征组。结果:男女性2型糖尿病合并代谢综合征组腰围、体质量、体质指数、收缩压、舒张压、空腹c肽、总胆固醇、甘油三酯和低密度脂蛋白胆固醇均高于未合并代谢综合征组(均P〈0.05),高密度脂蛋白胆固醇低于未合并代谢综合征组(P〈0.01)。合并代谢综合征组FRS男性[13.0(10.0,15.0)与11.0(9.0,13.0)]、女性[15.0(12.0,18.0)与12.0(6.0,14.8)]和10年心血管风险男性[12.0%(6.0%,20.0%)与8%(5.0%,12.0%)]、女性[3.0%(1.0%,6.0%)与1.0%(0.0%,2.8%)]均高于未合并代谢综合征组(均P〈0.01)。FRS和10年心血管风险随代谢综合征组分增加而增加。结论:2型糖尿病患者合并代谢综合征心血管危险因素增加,进一步增加FRS和10年心血管疾病风险。
Objective: To assess the impact of metabolic syndrome (MS) on Framingham risk score (FRS) in patients with type 2 diabetes mellitus (T2DM). Methods: The anthropometric and biochemical data of 1708 patients with T2DM admitted in hospital from May 2008 to April 2013 were retrospectively analyzed, including 902 males and 806 females with a mean age of 57.1 ± 11.8 years (20-79 years). Diagnosis of MS was made according to the criteria of the Adult Treatment Panel Ⅲ Criteria modified for Asians. Results: Compared to non-MS/T2DM patients, MS/T2DM patients had higher waist circumference, body weight, body mass index, systolic and diastolic blood pressure, fasting C peptide, total cholesterol, triglyceride, and LDL-C (P 〈 0.05), while lower HDL-C (P 〈 0.01 ). Both FRS [ 13.0( 10. 0, 15.0) vs 11.0(9.0, 13.0) in male,15.0(12.0, 18.0) vs 12.0(6.0, 14.8) in female,P 〈 0.01 ) ] and 10 - year cardiovascular risk [ 12.0% (6. 0%, 20. 0% ) vs 8.0%(5.0%,12.0%) in male,3.0%(1.0%, 6.0%) vs 1.0%(0.0%, 2.8%) in female,P 〈0. 01 ] were higher in MS/T2DM patients than those in non-MS/T2DM patients. Both FRS and 10-year cardiovascular risk were increased with the components of MS. Conclusion: T2DM patients with MS have more cardiovascular risk factors, higher FRS and 10-year cardiovascular risk.
出处
《浙江大学学报(医学版)》
CAS
CSCD
北大核心
2016年第3期268-274,共7页
Journal of Zhejiang University(Medical Sciences)
基金
国家自然科学基金(81370968)
中华医学会临床医学科研专项基金(13040620447)
浙江省教育厅科研项目(Y201328533)
关键词
糖尿病
2型/流行病学
代谢综合征X/并发症
心血管疾病/预防和控制
危险因素
complications
Diabetes mellitus, type 2/epidemiology
Cardiovascular diseases/prevention & control
Metabolic syndrome X/ Risk factors